David T Miyamoto Selected Research

David T Miyamoto Research Topics

29	Neoplasms (Cancer) 03/2024 - 03/2010
22	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 03/2010
15	Circulating Neoplastic Cells 03/2024 - 11/2012
10	Urinary Bladder Neoplasms (Bladder Cancer) 11/2023 - 12/2018
7	Neoplasm Metastasis (Metastasis) 01/2023 - 06/2013
4	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2011
2	Carcinogenesis 01/2023 - 01/2019
2	Vaginal Neoplasms (Cancer, Vaginal) 01/2016 - 01/2013
2	Pancreatic Neoplasms (Pancreatic Cancer) 09/2014 - 07/2010
1	Ataxia Telangiectasia (Louis Bar Syndrome) 11/2023
1	Urologic Neoplasms (Urological Cancer) 02/2023
1	Hydronephrosis 01/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Kidney Neoplasms (Kidney Cancer) 01/2021
1	Neoplasm Micrometastasis 01/2019
1	Melanoma (Melanoma, Malignant) 01/2018
1	Adenocarcinoma 01/2017
1	Disease Progression 01/2017
1	Hepatocellular Carcinoma (Hepatoma) 01/2017
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Hepatitis 01/2017
1	Genomic Instability 12/2016
1	Weight Gain 06/2014
1	Weight Loss (Weight Reduction) 07/2010

15	RNA (Ribonucleic Acid)IBA 03/2024 - 03/2010
15	Biomarkers (Surrogate Marker)IBA 02/2024 - 11/2016
4	Proteins (Proteins, Gene)FDA Link 03/2024 - 09/2014
4	AndrogensIBA 01/2020 - 11/2012
4	Androgen Receptors (Androgen Receptor)IBA 11/2017 - 11/2012
3	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 01/2021
3	Circulating Tumor DNAIBA 02/2023 - 11/2016
2	Cisplatin (Platino)FDA LinkGeneric 10/2023 - 11/2022
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2018
2	LigandsIBA 01/2019 - 01/2018
2	abirateroneIBA 01/2018 - 01/2017
2	EpitopesIBA 09/2014 - 04/2013
1	Radium-223IBA 02/2024
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 11/2023
1	HydrogelsIBA 06/2023
1	ChromatinIBA 01/2023
1	tyrosine receptor (receptor, tyrosine)IBA 01/2022
1	Epithelial Cell Adhesion MoleculeIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	ProteomeIBA 01/2021
1	herbal preparation PC-CAREIBA 01/2021
1	Hormones (Hormone)IBA 01/2020
1	Phenobarbital (Luminal)FDA Link 01/2020
1	ProlactinIBA 01/2019
1	Dinoprostone (PGE2)FDA Link 01/2019
1	Celecoxib (Celebrex)FDA Link 01/2019
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2019
1	Prolactin Receptors (Prolactin Receptor)IBA 01/2019
1	SolutionsIBA 01/2019
1	bicalutamide (Casodex)FDA LinkGeneric 01/2017
1	enzalutamideIBA 01/2017
1	N 30IBA 01/2017
1	GlobinsIBA 01/2017
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2016
1	gamma Catenin (Plakoglobin)IBA 08/2014
1	cabozantinibIBA 06/2013
1	Neoplasm Antigens (Tumor Antigens)IBA 04/2013
1	Prostate-Specific Antigen (Semenogelase)IBA 03/2010

22	Therapeutics 04/2024 - 03/2010
8	Radiotherapy 04/2024 - 07/2010
7	Cystectomy 10/2023 - 12/2018
6	Castration 02/2024 - 11/2012
4	Drug Therapy (Chemotherapy) 12/2018 - 07/2010
2	Prostatectomy (Retropubic Prostatectomy) 04/2024 - 01/2017
2	Precision Medicine 12/2020 - 11/2016
1	Adjuvant Chemotherapy 01/2023
1	Proton Therapy 03/2022
1	Immunotherapy 01/2021
1	Neoadjuvant Therapy 10/2018
1	Brachytherapy 01/2016
1	Lab-On-A-Chip Devices 07/2015
1	Drug Tapering 06/2013
1	Chemoradiotherapy 07/2010